Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group.


Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
ISSN: 1878-3562
Titre abrégé: Dig Liver Dis
Pays: Netherlands
ID NLM: 100958385

Informations de publication

Date de publication:
04 2021
Historique:
received: 17 07 2020
revised: 09 10 2020
accepted: 12 10 2020
pubmed: 15 11 2020
medline: 18 1 2022
entrez: 14 11 2020
Statut: ppublish

Résumé

Patients' experience with healthcare professionals could influence their clinical outcomes. To assess inflammatory bowel disease (IBD) patients' experience with their disease, their treatment and their relationship with their physician. A one-week cross-sectional study was conducted in 42 IBD centres. 2011 consecutive outpatients with IBD completed an anonymous self-report questionnaire assessing their experience with and knowledge of IBD. A quantitative assessment of the doctor-patient relationship revealed that patients' knowledge of IBD and IBD treatment ranged from 7.4 to 8.3 out of 10. In addition to IBD physicians, other sources of information about IBD and current treatment mainly included the internet (80% and 63%, respectively) and general practitioners (61% and 54%). Knowledge about education programmes (28%) was poor, resulting in a lack of willingness to further use these resources (25%). Concerns about IBD treatment were raised in 76% of patients, mostly related to the fear of adverse events (47%) and a lack of efficacy (33%). The need of alternative healthcare professionals was reported by 89% of the sample. In a large cohort of patients, we highlighted gaps in the management of patients with IBD regarding the need for higher-quality information and the implementation of alternative healthcare professionals.

Sections du résumé

BACKGROUND
Patients' experience with healthcare professionals could influence their clinical outcomes.
AIMS
To assess inflammatory bowel disease (IBD) patients' experience with their disease, their treatment and their relationship with their physician.
METHODS
A one-week cross-sectional study was conducted in 42 IBD centres. 2011 consecutive outpatients with IBD completed an anonymous self-report questionnaire assessing their experience with and knowledge of IBD.
RESULTS
A quantitative assessment of the doctor-patient relationship revealed that patients' knowledge of IBD and IBD treatment ranged from 7.4 to 8.3 out of 10. In addition to IBD physicians, other sources of information about IBD and current treatment mainly included the internet (80% and 63%, respectively) and general practitioners (61% and 54%). Knowledge about education programmes (28%) was poor, resulting in a lack of willingness to further use these resources (25%). Concerns about IBD treatment were raised in 76% of patients, mostly related to the fear of adverse events (47%) and a lack of efficacy (33%). The need of alternative healthcare professionals was reported by 89% of the sample.
CONCLUSION
In a large cohort of patients, we highlighted gaps in the management of patients with IBD regarding the need for higher-quality information and the implementation of alternative healthcare professionals.

Identifiants

pubmed: 33187920
pii: S1590-8658(20)30973-7
doi: 10.1016/j.dld.2020.10.020
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

434-441

Investigateurs

Aurelien Amiot (A)
Sara Tadbiri (S)
Charlotte Gagniere (C)
Jenny Tannoury (J)
Maria Nachury (M)
Benjamin Pariente (B)
Pauline Wils (P)
Yoram Bouhnik (Y)
Carmen Stefanescu (C)
Xavier Treton (X)
Melanie Serrero (M)
Jerome Filippi (J)
Xavier Hébuterne (X)
Nadia Arab (N)
Virginie Cluzeau (V)
Xavier Roblin (X)
Emilie Del Tedesco (ED)
Laurent Beaugerie (L)
Philippe Seksik (P)
Anne Bourrier (A)
Cecilia Landmann (C)
Julien Kirchgesner (J)
Harry Sokol (H)
Guillaume Bouguen (G)
Laurent Siproudhis (L)
Marie DeWitte (M)
Denis Franchimont (D)
Guillaume Savoye (G)
Anthony Buisson (A)
Edouard Louis (E)
Catherine Reenaers (C)
Stephane Nancey (S)
Gilles Boschetti (G)
Claire Gay (C)
Pauline Danion (P)
Bernard Flourié (B)
Vered Abitbol (V)
Georgia Malamut (G)
Jean-Marie Reimund (JM)
Benedicte Caron (B)
Olivier DeWitt (O)
Lucine Vuitton (L)
Nicolas Mathieu (N)
Sandie Pestour (S)
Laurent Peyrin-Biroulet (L)
Camille Zallot (C)
Cyrielle Gilletta (C)
Matthieu Allez (M)
Jean-Marc Gornet (JM)
Clotilde Baudry (C)
Stephanie Viennot (S)
Arnaud Bourreille (A)
Caroline Trang-Poisson (C)
Nina Dib (N)
Hedi Brixi (H)
Guillaume Cadiot (G)
Medina Boualit (M)
Claire Painchart (C)
Laurianne Plastaras (L)
Romain Altwegg (R)
Lucile Boivineau (L)
Mathurin Fumery (M)
Ludovic Caillo (L)
David Laharie (D)
Pauline Riviere (P)
Florian Poullenot (F)
Benoit Coffin (B)
Henri Duboc (H)
Stephane Nahon (S)
Noemie Tavernier (N)
Marion Simon (M)
Baya Coulibaly (B)
Morgane Amil (M)
Duveau Nicolas (D)
Sherine Khater (S)
Mehdi Kaassis (M)
Felix Goutorbe (F)
Driffa Moussata (D)
Laurence Picon (L)

Informations de copyright

Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Auteurs

Maria Nachury (M)

Department of Gastroenterology, CHU Lille, Service des Maladies de l'appareil digestif, F-59000 Lille, France.

Yoram Bouhnik (Y)

Department of Gastroenterology, IBD and Nutrition Support, Beaujon Hospital, University Paris 7 Denis Diderot, Clichy, France.

Melanie Serrero (M)

Hôpital Nord, Centre d'investigation clinique Marseille Nord, Université Méditerranée, Marseille, France.

Jerome Filippi (J)

Department of Gastroenterology and Clinical Nutrition, CHU of Nice, University Côte d'Azur, Nice, France.

Xavier Roblin (X)

Department of Gastroenterology, Saint-Etienne University Hospital, Saint-Etienne, France.

Julien Kirchgesner (J)

Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine, F-75012, ERL 1057 INSERM/UMRS 7203, UPMC Université Paris 6, Paris, France.

Guillaume Bouguen (G)

Department of Gastroenterology, CHU Rennes and University of Rennes, INCERM, CIC1414, NUMECAN institute, F-35000 Rennes, France.

Denis Franchimont (D)

Department of Gastroenterology, Hôpital Erasme, Laboratoire de Gastroenterologie experimentale, ULB, Brussels, Belgium.

Guillaume Savoye (G)

Department of Gastroenterology, Rouen University Hospital, Rouen, France.

Anthony Buisson (A)

Department of Hepato-Gastroenterology, University Hospital Estaing of Clermont-Ferrand, Université d'Auvergne, Clermont-Ferrand, France.

Edouard Louis (E)

Department of Gastroenterology, Liège University Hospital, CHU Liège, Belgium.

Stephane Nancey (S)

Department of Gastroenterology, Lyon-Sud hospital, Hospices Civils de Lyon and INSERM U1111, University Claude Bernard Lyon 1, Lyon, France.

Vered Abitbol (V)

Department of Gastroenterology, Cochin University Hospital, Paris, France.

Jean-Marie Reimund (JM)

Service d'Hépato-Gastroentérologie et d'Assistance Nutritive, Hôpitaux Universitaires de Strasbourg (Hôpital de Hautepierre) et INSERM U1113 IRFAC (Interface de Recherche Fondamentale et Appliquée en Cancérologie), Université de Strasbourg, Strasbourg, France.

Olivier DeWit (O)

Cliniques Universitaires Saint-Luc, UCL, Brussels, Belgium.

Lucine Vuitton (L)

Department of Gastroenterology, Besancon University Hospital, Besancon, France.

Nicolas Matthieu (N)

Department of Hepato-Gastroenterology and Digestive Oncology, Grenoble Alpes University Hospital, Grenoble, France.

Laurent Peyrin-Biroulet (L)

Department of Gastroenterology, Nancy Universisty Hospital, Inserm U1256 NGERE, Lorraine University, Vandoeuvre-les-Nancy, France.

Cyrielle Gilletta (C)

Department of Gastroenterology, Toulouse University Hospital, Toulouse, France.

Sara Tadbiri (S)

Department of Gastroenterology, Henri Mondor Hospital, APHP, EC2M3-EA7375, Paris Est-Créteil Val de Marne University, Creteil, France.

Matthieu Allez (M)

Department of Gastroenterology, Saint-Louis University Hospital, Paris, France.

Stephanie Viennot (S)

Department of Gastroenterology, Caen University Hospital, Caen, France.

Arnaud Bourreille (A)

Department of Gastroenterology, Nantes University Hospital, Nantes, France.

David Laharie (D)

Department of HepatoGastroenterology and Digestive Oncology, CHU Bordeaux, INSERM CIC 1401, Centre Medico-chirurgical Magellan, Haut-Leveque Hospital, Université de Bordeaux; Bordeaux, France.

Aurelien Amiot (A)

Department of Gastroenterology, Henri Mondor Hospital, APHP, EC2M3-EA7375, Paris Est-Créteil Val de Marne University, Creteil, France. Electronic address: aurelien.amiot@hmn.aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH